Cargando…
miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
Exosomes (EVs) have relevance in cell-to-cell communication carrying pro-tumorigenic factors that participate in oncogenesis and drug resistance and are proposed to have potential as self-delivery systems. Advancing on our studies of EVs in triple-negative breast cancer, here we more comprehensively...
Autores principales: | O'Brien, Keith, Lowry, Michelle C., Corcoran, Claire, Martinez, Vanesa G., Daly, Melissa, Rani, Sweta, Gallagher, William M., Radomski, Marek W., MacLeod, Roderick A.F., O'Driscoll, Lorraine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741729/ https://www.ncbi.nlm.nih.gov/pubmed/26416415 |
Ejemplares similares
-
2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype
por: O’Neill, Sadhbh, et al.
Publicado: (2019) -
Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes
por: Corcoran, Claire, et al.
Publicado: (2012) -
miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer
por: Corcoran, Claire, et al.
Publicado: (2014) -
An extensive study of potential inhibitors of extracellular vesicles release in triple-negative breast cancer
por: McNamee, Niamh, et al.
Publicado: (2023) -
Neratinib resistance and cross-resistance to other HER2-targeted drugs due to increased activity of metabolism enzyme cytochrome P4503A4
por: Breslin, Susan, et al.
Publicado: (2017)